World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
8498
World Ranking
4348
National Ranking
1977

Amy C. Weintrob publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Amy C. Weintrob sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 127 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Amy C. Weintrob D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Amy C. Weintrob sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Amy C. Weintrob is affiliated with George Washington University in the United States and has a research focus primarily within the field of Medicine, contributing to 56 publications in this area. Their work includes significant contributions to subfields such as Infectious Diseases, Epidemiology, Neurology, Pulmonary and Respiratory Medicine, and Hepatology.

The scientist's research extensively covers topics related to COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, and broader SARS-CoV-2 and COVID-19 research. Additional areas of investigation include HIV, Drug Use, Sexual Risk, Hepatitis B Virus Studies, Hepatitis C virus research, and HIV/AIDS Research and Interventions.

Frequent publication venues for their work include:

  • Open Forum Infectious Diseases
  • The Lancet Respiratory Medicine
  • Contemporary Clinical Trials
  • SSRN Electronic Journal
  • Annals of Internal Medicine

Coauthors who have collaborated repeatedly with Amy C. Weintrob include:

  • Nicole Engen
  • Eleftherios Mylonakis
  • Robin Dewar
  • Birgit Grund
  • Abdel G. Babiker

Selected recent papers authored or coauthored by Amy C. Weintrob are:

  • Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial (2022), The Lancet Respiratory Medicine
  • Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 (2022), Annals of Internal Medicine
  • Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis (2021), Arthritis & Rheumatology
  • Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial (2023), The Lancet Respiratory Medicine
  • 1026. Hepatitis B Reactivation in Persons with HIV with Positive Hepatitis B Core Antibody after Switching to Antiretroviral Therapy without Hepatitis B Activity (2023), Open Forum Infectious Diseases

Best Publications

  • Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center

    Joshua D. Hartzell;Robert Neff;Julie Ake;Robin Howard

  • Influence of HLA-C Expression Level on HIV Control

    Richard Apps;Richard Apps;Ying Qi;Ying Qi;Jonathan M. Carlson;Haoyan Chen;Haoyan Chen

  • Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long-Term Nonprogressors in the US Department of Defense HIV Natural History Study

    Jason F. Okulicz;Jason F. Okulicz;Vincent C. Marconi;Vincent C. Marconi;Michael L. Landrum;Michael L. Landrum;Scott Wegner

  • Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: A 20-year cohort study

    Nancy Crum-Cianflone;Katherine Huppler Hullsiek;Vincent Marconi;Vincent Marconi;Amy Weintrob;Amy Weintrob

  • Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals

    Mirko Paiardini;Barbara Cervasi;Barbara Cervasi;Helmut Albrecht;Alagarraju Muthukumar

  • Increasing rates of obesity among HIV-infected persons during the HIV epidemic

    Nancy Crum-Cianflone;Nancy Crum-Cianflone;Nancy Crum-Cianflone;Mollie Poehlman Roediger;Mollie Poehlman Roediger;Lynn Eberly;Lynn Eberly;Maryam Headd

  • Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.

    Nancy F. Crum-Cianflone;Nancy F. Crum-Cianflone;Katherine Huppler Hullsiek;Vincent C. Marconi;Vincent C. Marconi;Anuradha Ganesan;Anuradha Ganesan

  • Invasive Mold Infections Following Combat-related Injuries

    Tyler Warkentien;Carlos Rodriguez;Bradley Lloyd;Justin Wells

  • Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load

    Paul J. McLaren;Paul J. McLaren;Cedric Coulonges;István Bartha;István Bartha;Tobias L. Lenz

  • Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

    Unknown

  • Infection-associated clinical outcomes in hospitalized medical evacuees after traumatic injury: trauma infectious disease outcome study.

    David R. Tribble;Nicholas G. Conger;Susan Fraser;Todd D. Gleeson

  • Host Determinants of HIV-1 Control in African Americans

    Kimberly Pelak;David B. Goldstein;Nicole M. Walley;Jacques Fellay

  • Impact of depression on HIV outcomes in the HAART era

    Joshua D. Hartzell;Joshua D. Hartzell;Igor E. Janke;Amy C. Weintrob;Amy C. Weintrob

  • Hepatitis B Virus Coinfection Negatively Impacts HIV Outcomes in HIV Seroconverters

    Helen M. Chun;Mollie P. Roediger;Mollie P. Roediger;Katherine Huppler Hullsiek;Katherine Huppler Hullsiek;Chloe L. Thio

  • CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection

    Richard M. Dunham;Barbara Cervasi;Jason M. Brenchley;Helmut Albrecht

  • Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls

    Paul J. McLaren;Paul J. McLaren;Paul J. McLaren;Cédric Coulonges;Stephan Ripke;Stephan Ripke;Leonard van den Berg

  • Biofilms and persistent wound infections in United States military trauma patients: a case-control analysis.

    Kevin S Akers;Katrin Mende;Kristelle A Cheatle;Wendy C Zera

  • Infrequent Diagnosis of Primary Human Immunodeficiency Virus Infection: Missed Opportunities in Acute Care Settings

    Amy C. Weintrob;Julieta Giner;Prema Menezes;Ericka Patrick

  • Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?

    Nancy F Crum-Cianflone;Nancy F Crum-Cianflone;Greg Grandits;Sara Echols;Sara Echols;Anuradha Ganesan;Anuradha Ganesan

  • Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons.

    Nancy F. Crum-Cianflone;Mollie Poehlman Roediger;Mollie Poehlman Roediger;David J. Moore;Braden Hale;Braden Hale

  • Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study.

    Vincent C. Marconi;Vincent C. Marconi;Vincent C. Marconi;Gregory A Grandits;Gregory A Grandits;Amy C. Weintrob;Amy C. Weintrob;Helen Chun;Helen Chun

Frequent Co-Authors

Nancy F. Crum-Cianflone
Nancy F. Crum-Cianflone Naval Medical Center San Diego
Brian K. Agan
Brian K. Agan Uniformed Services University of the Health Sciences
Vincent C. Marconi
Vincent C. Marconi Emory University
Clinton K. Murray
Clinton K. Murray San Antonio Military Medical Center
Bruce D. Walker
Bruce D. Walker Harvard University
Jacques Fellay
Jacques Fellay École Polytechnique Fédérale de Lausanne
Paul I. W. de Bakker
Paul I. W. de Bakker Vertex Pharmaceuticals (United Kingdom)
Mary Carrington
Mary Carrington Ragon Institute of MGH, MIT and Harvard
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
David Goldstein
David Goldstein University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare and research. Many students consider accelerated programs like the easiest absn to get into to transition quickly into nursing roles while gaining foundational medical knowledge applicable to immunological studies.

Additionally, practical nursing credentials can serve as a stepping stone. Understanding which lpn programs are easiest to get into is beneficial for those seeking fast entry into patient care, which is often essential before specializing further in immunology or related fields.

Advanced roles such as Nurse Practitioners often require specialized degrees. Many students look into what is the easiest np program to find flexible, accessible options that balance academic rigor with practical experience in immunology-related healthcare settings.

For those focused on mental health nursing within immunology, programs that combine clinical training with specialization are valuable. The top online pmhnp programs provide excellent clinical placement rates, ensuring hands-on experience critical for careers intersecting immunology and psychiatric care.

Best Scientists Citing Amy C. Weintrob

Trending Scientists

Recently Published Articles